TECH · News · 20260806N
Acquisition / Partnership / Divestiture
BIO-TECHNE Corp · 2026-08-06 · Importance 65 · Surprise 60 · In source text
Bio-Techne recently agreed to be acquired by Merck KGaA. The proposed transaction is expected to strengthen Merck’s position in high-growth life science markets. The deal was cited alongside Merck’s increased 2026 outlook and stronger second-quarter results, but the reported coverage did not disclose a transaction value or closing timeframe.
Key facts
- Bio-Techne recently agreed to an acquisition by Merck KGaA. source
- The Manufacturers Life Insurance Company reduced its stake in Bio-Techne Corp (NASDAQ:TECH) by 26.1% in the first quarter, selling 39,950 shares and retaining 113,374 shares valued at $5.9 million. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | positive | probable | — | Bio-Techne recently agreed to an acquisition by Merck KGaA. |